Mutual Funds

A Bargain Hunter Stands Tall

Bruce Berkowitz survived the carnage better than nearly all his peers. Now he sees plenty of good values.

By Manuel Schiffres, Executive Editor

From Kiplinger's Personal Finance magazine, January 2009
Text Size T T

Advertisement

As a wretched 2008 draws to a close, Bruce Berkowitz displays mixed emotions. On the one hand, Fairholme fund, which he's run since its late-1999 launch, is again beating the stock market (by eight percentage points in early November). On the other hand, the fund is on track for its worst year ever (down 28%). And yet the swoon in share prices that is responsible for Fairholme's losses also brings a smile to Berkowitz's face. The candy store is wide open, and the bargain-hunting Berkowitz, 50, feels like a kid again.

Despite the 2008 loss, Fairholme's long-term record remains solid. From its inception through November 7, the fund returned 11% annualized. During the same period, Standard & Poor's 500-stock index lost 3% a year. Fairholme, which typically owns only about 25 stocks, has trailed the index in only one calendar year.

What really stands out about Berkowitz's performance, though, is how he escaped the ignominious fate of so many other value managers over the past year. He applied strict value criteria when he assessed stocks, and he adhered to the simple (but wise) rule of not investing in anything he couldn't understand. So Berkowitz was never tempted by the likes of AIG, Bear Stearns or Lehman Brothers, no matter how cheap their stocks had seemingly become.

To learn more about how Berkowitz operates, we visited him in his Miami office, located the length of a football field from Biscayne Bay.

KIPLINGER'S: What were you doing as the markets gyrated so dramatically in the fall?

BERKOWITZ: Although the fall in stock prices hurt our performance, it has been a blessing. We've been buying companies at prices that even when I was in my most pessimistic mood, I didn't think we would see so quickly. These are 1974-type valuations, and what's fascinating is that stocks fell to these levels not because of earnings issues but because of the sheer magnitude of the forced liquidations. So this is still a bargain hunter's dream.

We are selling that which is cheap to buy that which is cheaper, in order to make more money in the future and to help manage taxes for our shareholders. And we're pairing our stock positions with senior subordinated debt.

So you're buying the bonds of companies whose stock you own?

Yes. Some of the stocks we hold are so cheap that we fear the companies will be taken over at too cheap a price. So we're buying discounted bonds that have anti-takeover triggers, meaning the price of the bonds will immediately rise to 100 cents on the dollar on a change of control. And if we like the stock, we don't mind owning bonds that are yielding 15%, 16%, 17%.

A lot of well-known value investors fell on their faces the past year or two. Why did Fairholme hold up as well as it did?

Maybe it's because I don't invest in things I can't understand. Eighteen years ago, after the financial stocks got killed, I was a big buyer of Wells Fargo, Freddie Mac and MBIA. They were simpler businesses then -- and they were cheap and understandable. You could read an annual report or a 10-K and you knew what you were getting.

Or take American International Group. If you looked at an AIG annual report six or seven years ago, you saw one paragraph on derivatives. You look at an AIG annual report today and you see 15 pages on derivatives. I don't think company insiders fully understand what's going on, let alone outsiders. So if I don't understand something, I've learned to walk away.

Do you try to anticipate which sectors will do best?

We tend to react rather than to predict. We look at companies, count the cash, and then try to kill the company.

Kill?

We spend a lot of time thinking about what could go wrong with a company -- whether it's a recession, stagflation, zooming interest rates or a dirty bomb going off. We try every which way to kill our best ideas. If we can't kill it, maybe we're on to something. If you go with companies that are prepared for difficult times, especially if they're linked to managers who are engineered for difficult times, then you almost want those times because they plant the seeds of greatness.

Get Kiplinger's Personal Finance magazine for $12. Save 75%!

Discuss

Reader Comments (4)

Posted by: Tom at 12/30/2008 09:47:03 AM

He's a little misinformed on generic prescriptions. No active ingredients are changed, maybe just inert fillers or colorings. The chemical fomula certainly is not different. The FDA has strict regulations on generic manufacturers requiring the drug to test within a certain percent activity of a brand name drug. That said, there is still a population willing to shell out extra cash for the brand.

Posted by: Julie at 12/30/2008 02:03:17 PM

He's also a little misinformed on St. Joe; perhaps he hasn't learned from his past mistake of "a total misjudgment of the character of management. Our biggest mistakes have always involved overestimating management." If you are a socially-caring or environmentally-aware investor, you wouldn't buy "Joe" stock. Read the book "Green Empire" by June Wiaz and Kathryn Ziewitz and you'll understand why "Joe" is not one to invest in or trust with your money. With real estate in Florida facing the highest foreclosure rates & more developers going bankrupt every day, putting your money into Florida real estate developers is a wrong choice.

Posted by: Closer at 01/04/2009 11:08:52 AM

For a contrasting view of Fairholme's recent performance, see "Mutual Fund Fought Off Bears but Now is Clawed" by Eleanor Laise in the Jan. 3/4 Wall Street Journal. Excerpt: "I'm horribly upset about our performance. I do believe it's temporary," Mr. Berkowitz...said in an interview." He was commenting on the fund's drop of 24% in the last three montha of 2008. There are some inconsistencies in what he told Kiplinger's from what he has told other media and shareholders in the past (like accumulating Pfizer stock without meeting the "jockeys," as he has called them).

Posted by: Mike at 01/19/2009 08:46:19 PM

I had to check to make sure this wasn't the April 1'st issue when I read this story. First, on Wellcare, saying it's "fine"..... no, it's not. It tanked and it's still there. The internet-only assessment of stocks. Leucadia will "probably give all the money to their shareholders".... yeah, right! The generic comments as pointed out by Tom lack insight. And then... to top it off... land in Florida! This guy's nuts!

Today's Video More Videos >>

Save Money in February

E-mail Alerts: Select the Kiplinger columns and topics to be delivered to your inbox:

Advertisement